Northwestern to Study New Alzheimer’s Disease Drug
More than 5 million Americans are living with Alzheimer’s disease, including 230,000 in Illinois. By 2050, that number is projected to rise to nearly 14 million Americans, according to the Alzheimer’s Association.
There is no cure for the neurodegenerative condition, symptoms of which include memory loss, difficulty completing daily tasks and challenges in planning or solving problems.
Many clinical trials are focused on prevention or disease-modifying therapies, which tend to exclude people who are already experiencing symptoms, says Northwestern University neurologist Dr. Ian Grant. While those types of therapies could eventually lead to a cure, Grant says it’s also important to study therapies that alleviate symptoms. The T2 Protect AD study seeks to do just that.
Read the full article HERE